ArticleDiagnostics (Basel, Switzerland)2023
Identifying Effective Feature Selection Methods for Alzheimer's Disease Biomarker Gene Detection Using Machine Learning.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Feature Selection Analysis and Robustness to Missing Data for Sensor-Based Prognostic Modeling of Alzheimer's Disease Progression.Sensors (Basel, Switzerland) · 2026Article
- LASSO-HHO two-stage hybrid gene selection framework for accurate Alzheimer's disease diagnosis.Scientific reports · 2026Article
- Neurophysiological connectomic signatures of consciousness during propofol-induced general anesthesia.Cell reports. Medicine · 2026Article
- A Scoping Review of Machine Learning-Based Prediction of Alzheimer's Disease Using Blood Biomarkers.Biomedical engineering and computational biology · 2026Review
- Electroencephalography for early Alzheimer's disease diagnosis: from advanced feature engineering to interpretable ai and clinical translation.Frontiers in psychiatry · 2026Review
- Cross-cohort genetic risk prediction for Alzheimer's disease: a transfer learning approach using GWAS and deep learning models.BioData mining · 2025Article
- Efficient Explainable Models for Alzheimer's Disease Classification with Feature Selection and Data Balancing Approach Using Ensemble Learning.Diagnostics (Basel, Switzerland) · 2024Article
- Methods in DNA methylation array dataset analysis: A review.Computational and structural biotechnology journal · 2024Review
- Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review.Diagnostics (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is a complex genetic disorder that affects the brain and has been the focus of many bioinformatics research studies. The primary objective of these studies is to identify and classify genes involved in the progression of AD and to explore the function of these risk genes in the disease process. The aim of this research is to identify the most effective model for detecting biomarker genes associated with AD using several feature selection methods. We compared the efficiency of feature selection methods with an SVM classifier, including mRMR, CFS, the Chi-Square Test, F-score, and GA. We calculated the accuracy of the SVM classifier using validation methods such as 10-fold cross-validation. We applied these feature selection methods with SVM to a benchmark AD gene expression dataset consisting of 696 samples and 200 genes. The results indicate that the mRMR and F-score feature selection methods with SVM classifier achieved a high accuracy of around 84%, with a number of genes between 20 and 40. Furthermore, the mRMR and F-score feature selection methods with SVM classifier outperformed the GA, Chi-Square Test, and CFS methods. Overall, these findings suggest that the mRMR and F-score feature selection methods with SVM classifier are effective in identifying biomarker genes related to AD and could potentially lead to more accurate diagnosis and treatment of the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.